
	Larry Bullock has been appointed as Chief Financial Officer of AGTC since January 31, 2014. Mr.Bullock has more than 30 years of financial executive management experience, including over two decades as a chief financial officer in the biotechnology industry. In his previous positions as Chief Financial Officer, he has successfully navigated the IPO process three times, building a body of expertise in all aspects of the financial management of a biotechnology company, including private and public company financing, SEC reporting, and establishing collaborations and licensing agreements between biotechnology and pharmaceutical companies. Mr. Bullock also has experience in marketing-based financial analysis, operations management, and sales.
